The Venture Codex Logo

The Venture Codex

GF Xinde Life Science Investment Fund

Grand Metropolitan Plaza, 16th Floor Tianhe North Road, 183, Guangzhou, Guangdong, 510620, China

Overview

Cross-border venture capital fund for biopharmaceutical companies.

Deals · 12mo

0

Links

Website

Stage focus

Series A

Geographic focus

United States

Sector focus

—

Investment portfolio

2rounds
NAMEDATESIZE
KBP Biosciences
Jan 2018Participated
$76 MSeries A
Twist Bioscience
Jun 2017Participated
$27 MOther Equity
KBP Biosciences
Jan 2018Participated
$76 MSeries A
Twist Bioscience
Jun 2017Participated
$27 MOther Equity
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

GF Xinde Life Science Investment Fund: 2 funding rounds are recorded in the selected participation categories.All available history.
GF Xinde Life Science Investment Fund: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Other Equity01

Monthly Deal Activity

GF Xinde Life Science Investment Fund: 2 deals are recorded across 113 months.All available history.
GF Xinde Life Science Investment Fund: 2 deals are recorded across 113 months. All available history
MonthDeals
Jun '171
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '181
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

GF Xinde Life Science Investment Fund: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

GF Xinde Life Science Investment Fund: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2
Space & Frontier Tech1

Deal Size Distribution

GF Xinde Life Science Investment Fund: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

GF Xinde Life Science Investment Fund: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M0
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

GF Xinde Life Science Investment Fund: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

GF Xinde Life Science Investment Fund: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
GF Xinde Life Science Investment Fund: 16 co-investors are shown, with Bay City Capital sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

GF Xinde Life Science Investment Fund: 16 co-investors are shown, with Bay City Capital sharing 2 recorded deals. All available history
Co-investorShared deals
Bay City Capital2
3W Partners1
Advantech Capital1
Biomatics Capital1
Cash Capital1
Ditch Plains Capital Management1
Efung Capital1
Elite Capital1
FIS1
Guotou Chuangye1
KANGMEI Group1
Korea Investment Partners1
NFT Investment Limited1
Ping An Ventures1
Reinet Investments1
Sangel Capital1

Investment Strategy

GF Xinde Life Science Investment Fund: Led accounts for 0% and participating for 100% of round participation.All available history.
GF Xinde Life Science Investment Fund: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
GF Xinde Life Science Investment Fund: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
GF Xinde Life Science Investment Fund: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

No team members found for this fund.